RecruitingNCT06417502

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Sponsor

Peking Union Medical College Hospital

Enrollment

20,000 participants

Start Date

Apr 29, 2022

Study Type

OBSERVATIONAL

Conditions

Autoimmune Diseases Autoinflammatory Diseases

Summary

An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.

Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is creating a national registry in China to collect clinical data on children and teenagers with rheumatic and immune system diseases. The goal is to better understand these conditions, track how they progress, and improve treatment approaches for young patients. **You may be eligible if...** - You are 18 years old or younger - You have been diagnosed with a rheumatic or immunologic disease (such as lupus, juvenile arthritis, vasculitis, or an immune deficiency disorder) - You are being diagnosed and treated in China **You may NOT be eligible if...** - You or your family do not agree to participate in the registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.